| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |